BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuchay MS, Martínez-Montoro JI, Choudhary NS, Fernández-García JC, Ramos-Molina B. Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges. Biomedicines 2021;9:1346. [PMID: 34680463 DOI: 10.3390/biomedicines9101346] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao N, Deng J, Wang J, Zhou Z, Yao C, Zhou M, Xing X, Wang Q, Lu X, Shi H. The prevalence, comorbidities, influencing factors, and identifying factors of non-obese fatty liver disease. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1038475] [Reference Citation Analysis]
2 Cavalcante LN, Dezan MGF, Paz CLDSL, Lyra AC. RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. Arq Gastroenterol 2022. [DOI: 10.1590/s0004-2803.202204000-93] [Reference Citation Analysis]
3 Cong F, Zhu L, Deng L, Xue Q, Wang J. Correlation between nonalcoholic fatty liver disease and early left ventricular diastolic dysfunction in non-obese adults: a cross-sectional study.. [DOI: 10.21203/rs.3.rs-2017919/v1] [Reference Citation Analysis]
4 Cazac GD, Lăcătușu CM, Mihai C, Grigorescu ED, Onofriescu A, Mihai BM. New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis. Life (Basel) 2022;12:1189. [PMID: 36013368 DOI: 10.3390/life12081189] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Dai C, Fang T, Hung W, Tsai H, Tsai Y. The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Biomedicines 2022;10:1487. [DOI: 10.3390/biomedicines10071487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang XL, Wang TY, Targher G, Byrne CD, Zheng MH. Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease. Diabetes Metab J 2022;46:391-401. [PMID: 35656562 DOI: 10.4093/dmj.2022.0048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bashir A, Duseja A, De A, Mehta M, Tiwari P. Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena. Liver Research 2022. [DOI: 10.1016/j.livres.2022.05.002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Kennedy L, Francis H, Alpini G. Macrophage-Specific SCAP Promotes Liver and Adipose Tissue Damage in a Lean NAFLD Model: Lean, Mean, Proinflammatory Machine. Cell Mol Gastroenterol Hepatol 2022:S2352-345X(22)00069-8. [PMID: 35500675 DOI: 10.1016/j.jcmgh.2022.04.004] [Reference Citation Analysis]
9 Boonchai P, Kositamongkol C, Jitrukthai S, Phothirat S, Mepramoon E, Nimitpunya P, Srivanichakorn W, Chaisathaphol T, Washirasaksiri C, Auesomwang C, Sitasuwan T, Tinmanee R, Sayabovorn N, Charatcharoenwitthaya P, Phisalprapa P. Clinical Differences and Non-Alcoholic Fatty Liver Disease-Related Factors of Lean and Non-Lean Patients with Metabolic Syndrome. J Clin Med 2022;11:2445. [PMID: 35566571 DOI: 10.3390/jcm11092445] [Reference Citation Analysis]
10 Trifan A, Rotaru A, Stafie R, Stratina E, Zenovia S, Nastasa R, Huiban L, Cuciureanu T, Muzîca C, Chiriac S, Gîrleanu I, Sîngeap A, Sfarti C, Cojocariu C, Stanciu C. Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease. Diagnostics 2022;12:801. [DOI: 10.3390/diagnostics12040801] [Reference Citation Analysis]
11 DiStefano JK, Gerhard GS. NAFLD in normal weight individuals. Diabetol Metab Syndr 2022;14:45. [PMID: 35331317 DOI: 10.1186/s13098-022-00814-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kuchay MS, Misra A. Role of diabetologists in the management of nonalcoholic fatty liver disease: Primary prevention and screening/management of fibrosis and cirrhosis. Diabetes Metab Syndr 2022;16:102446. [PMID: 35259705 DOI: 10.1016/j.dsx.2022.102446] [Reference Citation Analysis]